Drug toxicity
Information
- Disease name
- Drug toxicity
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04138381 | Active, not recruiting | Phase 1/Phase 2 | Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) | August 16, 2019 | April 16, 2023 |
| NCT03651778 | Active, not recruiting | GHB Poisoning and Poisoning Induced by Others | September 1, 2018 | December 31, 2024 | |
| NCT06019520 | Active, not recruiting | N/A | Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity | August 9, 2023 | March 9, 2024 |
| NCT00491595 | Completed | Phase 1 | Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women | March 2004 | July 2005 |
| NCT00743093 | Completed | Phase 4 | Aminotransferase Trends During Prolonged Acetaminophen Dosing | August 2008 | August 2011 |
| NCT01135680 | Completed | Phase 1 | Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100 | May 2010 | September 2010 |
| NCT01239121 | Completed | N/A | Regional Data Exchange to Improve Medication Safety | February 2012 | June 2016 |
| NCT00002586 | Completed | Phase 2 | 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer | January 1993 | December 2005 |
| NCT01614080 | Completed | Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA | November 2011 | December 2014 | |
| NCT00017004 | Completed | Phase 3 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | August 2001 | |
| NCT00166608 | Completed | Cytokines Polymorphisms and Acetaminophen Toxicity | December 2002 | September 2007 | |
| NCT01979380 | Completed | Phase 1 | Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects | December 2013 | August 2014 |
| NCT02864030 | Completed | Phase 4 | PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment | May 2014 | December 31, 2020 |
| NCT03265613 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis | September 24, 2017 | November 28, 2019 |
| NCT03280368 | Completed | Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation | June 2014 | January 2020 | |
| NCT03392311 | Completed | Phase 1/Phase 2 | Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis | July 23, 2019 | March 19, 2020 |
| NCT03461445 | Completed | Phase 4 | A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients | April 1, 2018 | July 31, 2023 |
| NCT03825224 | Completed | Evaluation of MyoStrain™ in Clinical Practice | April 15, 2019 | November 15, 2019 | |
| NCT03882541 | Completed | N/A | Could Music be an Alternative to Sedation in Patients Treated Total Knee Arthroplasty With Regional Anesthesia? | January 8, 2017 | January 30, 2018 |
| NCT03947034 | Completed | Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) | May 1, 2019 | April 4, 2023 | |
| NCT03994302 | Completed | Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) | June 1, 2019 | April 8, 2023 | |
| NCT04120233 | Completed | Phase 1 | MW151-101: First-in-human Study of MW151 | October 22, 2019 | September 16, 2021 |
| NCT04275024 | Completed | N/A | Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients | April 1, 2020 | February 3, 2021 |
| NCT05237492 | Completed | Phase 4 | The Influence of Tramadol on Platelet Function | January 26, 2022 | July 15, 2023 |
| NCT05691309 | Completed | Optimizing Vancomycin Therapy in Children | December 12, 2022 | November 22, 2023 | |
| NCT05472350 | Not yet recruiting | N/A | Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy | August 1, 2022 | November 1, 2023 |
| NCT05851222 | Not yet recruiting | A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP) | August 1, 2023 | December 31, 2024 | |
| NCT06214468 | Recruiting | Phase 1 | Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity | January 15, 2024 | April 30, 2025 |
| NCT05512169 | Recruiting | Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia | December 1, 2022 | March 30, 2026 | |
| NCT05899751 | Recruiting | Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate | April 1, 2022 | December 2024 | |
| NCT04659343 | Recruiting | TDM for Optimized Outcome in Patients With mRCC. | November 1, 2020 | May 1, 2027 | |
| NCT05329142 | Recruiting | ASSIST: A Surveillance Study of Illicit Substance Toxicity | August 19, 2022 | August 19, 2023 | |
| NCT04305145 | Recruiting | Phase 2 | Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis | August 31, 2020 | June 30, 2030 |
| NCT05022797 | Terminated | Phase 2 | Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS | July 19, 2021 | November 22, 2022 |
| NCT00090844 | Terminated | Phase 2 | Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer | July 2004 | May 2008 |
| NCT00213642 | Terminated | Tc-99m Renography and Cisplatin-induced Nephrotoxicity | July 2001 | August 2004 | |
| NCT03885388 | Unknown status | Phase 2/Phase 3 | Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6 | March 8, 2019 | December 31, 2023 |
| NCT01965275 | Unknown status | Phase 2 | High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs | October 2013 | December 2017 |
| NCT04671589 | Unknown status | Phase 4 | Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic. | June 2021 | December 2022 |
| NCT02439658 | Unknown status | Genetics of QT Prolongation With Antiarrhythmics | January 2014 | April 30, 2023 | |
| NCT04696081 | Unknown status | Atrial Fibrillation in Active Cancer Patients | September 1, 2021 | January 1, 2024 | |
| NCT04747678 | Unknown status | Adverse Effects of Ivermectin Used in Egypt During COVID-19 | February 3, 2021 | March 1, 2021 | |
| NCT04987801 | Unknown status | Evaluation of Drug Overdose Poisoning Cases and Indications for ICU Admission | April 1, 2021 | March 31, 2022 | |
| NCT03469063 | Unknown status | N/A | Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients | June 28, 2018 | June 30, 2020 |
| NCT03745417 | Unknown status | Phase 1/Phase 2 | Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis | August 31, 2021 | December 31, 2022 |
| NCT01374061 | Withdrawn | Phase 4 | Pre Hospital Evaluation of Video Laryngoscopy | June 2011 | December 2012 |